About CannMed
CannMed features the greatest minds in medical cannabis. With a booming industry anticipated to exceed $500B by 2028, understanding the complex science and its medical benefits for patients in need is how this conference series was born. Since our inaugural event at Harvard Medical School in 2016, we have been passionately driven to further the scientific and cultural dialogue. Medicinal Genomics invites all attendees or sponsors to experience firsthand why CannMed continues to lead the way in cannabis science.
HIGHLIGHTS:
New venue, one location!
Cocktail hour networking parties
Expanded exhibit space
Multiple ticket price options
Expanded speaker times and Q&A
CME credits available (details coming soon)
Speakers
DAVID MEIRI
Laboratory of Cancer Biology & Cannabinoid Research - Technion
View More (8)
Kevin McKernan
CSO at Medicinal Genomics Corporation
Staci Gruber
McLean Hospital Brain Imaging Center Harvard Medical School
Kevin Fisher
CEO/Co-Founder, Molecular Infusions RK Enterprises Ltd
Sponsors
View More (6)
